Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean J Gastrointest Endosc. 2008 Oct;37(4):308-311. Korean. Case Report.
Park HJ , Han DS , Kim HC , Cho HS , Eun CS , Jeon YC , Sohn JH , Choi JH .
Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea.

S-1 (TS-1) is an oral anticancer drug that contains a prodrug of 5-fluorouracil. This drug exhibits high efficacy with it is used as single therapy or in combination therapy for gastrointestinal cancer, and especially advanced gastric cancer. There have not been any reports about grade 3 or 4 adverse events when using S-1. We report here on a case of multiple colon ulcers after S-1 chemotherapy in a patient with advanced gastric cancer.

Copyright © 2019. Korean Association of Medical Journal Editors.